ABEO logo

Abeona Therapeutics (ABEO) Operating Expenses

Annual Operating Expenses

$50.09 M
+$3.87 M+8.38%

December 31, 2023


Summary


Performance

ABEO Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABEOexpensesmetrics:

Quarterly Operating Expenses

$15.35 M
-$2.52 M-14.10%

September 30, 2024


Summary


Performance

ABEO Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABEOexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

ABEO Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.4%+16.2%
3 y3 years-14.4%+3.2%
5 y5 years-18.1%-13.1%

ABEO Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-17.0%+8.4%-14.1%+63.6%
5 y5-year-35.0%+8.4%-14.1%+63.6%
alltimeall time-35.0%+1823.8%-36.0%+1328.6%

Abeona Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$15.35 M(-14.1%)
Jun 2024
-
$17.86 M(+24.7%)
Mar 2024
-
$14.33 M(+8.5%)
Dec 2023
$50.09 M(+8.4%)
$13.21 M(+16.9%)
Sep 2023
-
$11.30 M(-16.5%)
Jun 2023
-
$13.54 M(+12.5%)
Mar 2023
-
$12.04 M(+0.7%)
Dec 2022
$46.22 M(-23.4%)
$11.95 M(+27.4%)
Sep 2022
-
$9.38 M(-7.3%)
Jun 2022
-
$10.12 M(-31.5%)
Mar 2022
-
$14.77 M(-14.1%)
Dec 2021
$60.37 M(+3.2%)
$17.19 M(+15.6%)
Sep 2021
-
$14.87 M(+8.4%)
Jun 2021
-
$13.71 M(-6.0%)
Mar 2021
-
$14.60 M(-16.5%)
Dec 2020
$58.50 M(-24.1%)
$17.48 M(+31.9%)
Sep 2020
-
$13.25 M(+6.1%)
Jun 2020
-
$12.48 M(-18.4%)
Mar 2020
-
$15.29 M(-6.8%)
Dec 2019
$77.09 M(+26.0%)
$16.41 M(-7.0%)
Sep 2019
-
$17.65 M(-26.4%)
Jun 2019
-
$23.98 M(+25.8%)
Mar 2019
-
$19.05 M(+3.0%)
Dec 2018
$61.16 M(+113.3%)
$18.49 M(-0.7%)
Sep 2018
-
$18.63 M(+45.1%)
Jun 2018
-
$12.83 M(+14.4%)
Mar 2018
-
$11.21 M(+25.1%)
Dec 2017
$28.67 M(+15.8%)
$8.96 M(+60.6%)
Sep 2017
-
$5.58 M(-35.5%)
Jun 2017
-
$8.66 M(+58.3%)
Mar 2017
-
$5.47 M(-10.2%)
Dec 2016
$24.77 M(+26.5%)
$6.09 M(+13.6%)
Sep 2016
-
$5.36 M(-22.7%)
Jun 2016
-
$6.93 M(+8.4%)
Mar 2016
-
$6.39 M(-1.1%)
Dec 2015
$19.59 M(+382.9%)
$6.47 M(+0.3%)
Sep 2015
-
$6.45 M(+46.3%)
Jun 2015
-
$4.41 M(+95.1%)
Mar 2015
-
$2.26 M(+222.4%)
Dec 2014
$4.06 M(-29.1%)
$701.00 K(-19.3%)
Sep 2014
-
$869.00 K(-8.5%)
Jun 2014
-
$950.00 K(-38.2%)
Mar 2014
-
$1.54 M(+81.6%)
Dec 2013
$5.72 M(-32.3%)
$846.00 K(-3.6%)
Sep 2013
-
$878.00 K(-62.4%)
Jun 2013
-
$2.33 M(+40.5%)
Mar 2013
-
$1.66 M(-23.0%)
Dec 2012
$8.45 M(-11.6%)
$2.16 M(+23.5%)
Sep 2012
-
$1.75 M(-15.9%)
Jun 2012
-
$2.08 M(-15.7%)
Mar 2012
-
$2.47 M(+14.9%)
Dec 2011
$9.57 M
$2.15 M(-22.3%)
Sep 2011
-
$2.76 M(+16.8%)
DateAnnualQuarterly
Jun 2011
-
$2.37 M(+7.2%)
Mar 2011
-
$2.21 M(+17.1%)
Dec 2010
$8.10 M(-19.2%)
$1.89 M(-22.2%)
Sep 2010
-
$2.42 M(+18.5%)
Jun 2010
-
$2.04 M(+17.2%)
Mar 2010
-
$1.75 M(-2.5%)
Dec 2009
$10.03 M(-67.7%)
$1.79 M(-56.2%)
Sep 2009
-
$4.08 M(+89.5%)
Jun 2009
-
$2.15 M(+7.8%)
Mar 2009
-
$2.00 M(+10.6%)
Dec 2008
$31.02 M(+345.9%)
$1.81 M(-53.8%)
Sep 2008
-
$3.92 M(+71.3%)
Jun 2008
-
$2.29 M(-78.4%)
Mar 2008
-
$10.60 M(+440.0%)
Dec 2007
$6.96 M(+34.4%)
$1.96 M(+18.5%)
Sep 2007
-
$1.66 M(-3.1%)
Jun 2007
-
$1.71 M(+5.1%)
Mar 2007
-
$1.63 M(+55.5%)
Dec 2006
$5.17 M(-46.2%)
$1.05 M(-16.7%)
Sep 2006
-
$1.26 M(-8.6%)
Jun 2006
-
$1.37 M(-8.3%)
Mar 2006
-
$1.50 M(-67.2%)
Dec 2005
$9.62 M(+60.3%)
$4.57 M(+285.7%)
Sep 2005
-
$1.19 M(-53.6%)
Jun 2005
-
$2.55 M(+94.4%)
Mar 2005
-
$1.31 M(-304.5%)
Dec 2004
$6.00 M(+10.6%)
-$642.00 K(-127.0%)
Sep 2004
-
$2.37 M(+7.3%)
Jun 2004
-
$2.21 M(+7.5%)
Mar 2004
-
$2.06 M(-264.8%)
Dec 2003
$5.43 M(-44.3%)
-$1.25 M(-164.9%)
Sep 2003
-
$1.92 M(-15.4%)
Jun 2003
-
$2.27 M(-8.3%)
Mar 2003
-
$2.48 M(-8.7%)
Dec 2002
$9.74 M(+48.7%)
$2.71 M(-1.9%)
Sep 2002
-
$2.77 M(+16.2%)
Jun 2002
-
$2.38 M(+26.7%)
Mar 2002
-
$1.88 M(+20.4%)
Dec 2001
$6.55 M(+6.3%)
$1.56 M(-15.8%)
Sep 2001
-
$1.85 M(+16.4%)
Jun 2001
-
$1.59 M(+3.4%)
Mar 2001
-
$1.54 M(-19.1%)
Dec 2000
$6.17 M(+83.3%)
$1.90 M(+27.5%)
Sep 2000
-
$1.49 M(-10.5%)
Jun 2000
-
$1.67 M(+51.6%)
Mar 2000
-
$1.10 M(+14.1%)
Dec 1999
$3.36 M(-3.9%)
$964.00 K(+37.7%)
Sep 1999
-
$700.00 K(-12.5%)
Jun 1999
-
$800.00 K(0.0%)
Mar 1999
-
$800.00 K
Dec 1998
$3.50 M(-20.1%)
-
Dec 1997
$4.38 M(+26.3%)
-
Dec 1996
$3.47 M(+33.1%)
-
Dec 1995
$2.60 M
-

FAQ

  • What is Abeona Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Abeona Therapeutics?
  • What is Abeona Therapeutics annual operating expenses year-on-year change?
  • What is Abeona Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Abeona Therapeutics?
  • What is Abeona Therapeutics quarterly operating expenses year-on-year change?

What is Abeona Therapeutics annual total operating expenses?

The current annual operating expenses of ABEO is $50.09 M

What is the all time high annual operating expenses for Abeona Therapeutics?

Abeona Therapeutics all-time high annual total operating expenses is $77.09 M

What is Abeona Therapeutics annual operating expenses year-on-year change?

Over the past year, ABEO annual total operating expenses has changed by +$3.87 M (+8.38%)

What is Abeona Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of ABEO is $15.35 M

What is the all time high quarterly operating expenses for Abeona Therapeutics?

Abeona Therapeutics all-time high quarterly total operating expenses is $23.98 M

What is Abeona Therapeutics quarterly operating expenses year-on-year change?

Over the past year, ABEO quarterly total operating expenses has changed by +$2.14 M (+16.17%)